New York State Department of Health, Albany, New York, USA.
New Jersey Department of Health, Trenton, New Jersey, USA.
Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0224221. doi: 10.1128/aac.02242-21. Epub 2022 Jan 10.
About 55% of U.S. Candida auris clinical cases were reported from New York and New Jersey from 2016 through 2020. Nearly all New York-New Jersey clinical isolates (99.8%) were fluconazole resistant, and 50% were amphotericin B resistant. Echinocandin resistance increased from 0% to 4% and pan-resistance increased from 0 to <1% for New York C. auris clinical isolates but not for New Jersey, highlighting the regional differences.
从 2016 年到 2020 年，美国约有 55%的假丝酵母菌属耳念珠菌临床病例报告来自纽约和新泽西。几乎所有来自纽约-新泽西的临床分离株（99.8%）对氟康唑具有耐药性，50%对两性霉素 B 具有耐药性。棘白菌素类耐药性从 0%增加到 4%，泛耐药性从 0%增加到纽约耳念珠菌临床分离株的<1%，但新泽西没有增加，突出了区域差异。
